سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Effects of endocannabinoid system, synthetic and nonsynthetic cannabinoid drugs on traumatic brain injury outcome: a narrative review

Publish Year: 1397
Type: Journal paper
Language: English
View: 75

This Paper With 12 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_JSTR-7-1_002

Index date: 26 December 2023

Effects of endocannabinoid system, synthetic and nonsynthetic cannabinoid drugs on traumatic brain injury outcome: a narrative review abstract

Traumatic brain injury (TBI) is the leading cause of morbidity and mortality worldwide. The initial injury is followed by a series of secondary processes that can further harm the injured brain and worsen the outcome. The endocannabinoid system (ECS) consists of ligands, such as anandamide and 2-arachidonoyl-glycerol (2-AG), receptors (e.g., Cannabinoid receptor type 1 and Cannabinoid receptor type 2), as well as transporters, and enzymes. Dexanabinol (HU-211) is a synthetic cannabinoid with cerebroprotective effects devoid of cannabimimetic effects, which exhibits the pharmacological properties of N-Methyl-D-aspartate receptor antagonist. The increase in the brain levels of endocannabinoids in the pathogenic events of brain injury suggests that this system plays a role in compensatory repair mechanisms. In recent year, the therapeutic effects of cannabinoid manipulative drugs have been numerously studied through the manipulation of the ECS in TBI. Therefore, the literature review was performed to assess the therapeutic effects of ECS manipulation, cannabinoid-derived drugs, and HU-211 in traumatic brain injury pathology. The ECS possesses promising effects in the treatment of diverse TBI pathologies through releasing endogenous ligands and changes in cannabinoid receptors activity or both. Preclinical studies suggest that the ECS has many targets for therapeutic agents that might help decrease TBI pathologic effects and should be considered for developing novel drugs. Furthermore, more clinical trials with larger populations and more  extended follow-up periods should be performed for a better understanding of the effects of ECS manipulative drugs.

Effects of endocannabinoid system, synthetic and nonsynthetic cannabinoid drugs on traumatic brain injury outcome: a narrative review Keywords:

Effects of endocannabinoid system, synthetic and nonsynthetic cannabinoid drugs on traumatic brain injury outcome: a narrative review authors

Ahmad Amouzeshi

Associate Professor, Department of Cardiac Surgery, Birjand University of Medical Sciences, Birjand, Iran

Ali Mohammad Pourbagher-Shahri

MD, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Bagalman E. Traumatic brain injury among veterans. Congressional Research Service, ...
Mazlan M. ۴۳-Traumatic brain injury. In: Cifu DX, Lew HL, ...
Menon DK, Schwab K, Wright DW, Maas AI. Position statement: ...
Winkler EA, Minter D, Yue JK, Manley GT. Cerebral edema ...
نمایش کامل مراجع